FM
ICPT

Family Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Family Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,400
Closed -$232K – 93
2015
Q3 		$232K Buy
+1,400
New +$308K 0.1% 83

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Family Management's ICPT Position: Q4 2015 in Review

Family Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2015, closing a stake of 1,400 shares — an estimated $232K sold.

Family Management first reported a position in ICPT in Q3 2015 and held it in 1 quarter. The position peaked at $232K in Q3 2015. 172 funds tracked by Wall St. Rank hold ICPT as of Q4 2015.

  • Family Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Family Management sold 1,400 Intercept Pharmaceuticals, Inc. shares in Q4 2015, an estimated $232K.
  • Family Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • Family Management's Intercept Pharmaceuticals, Inc. position peaked at $232K in Q3 2015.
  • 172 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2015.

Based on Family Management's 13F filing for Q4 2015, filed 9 Feb 2016.